Remodulin and Hypertension aggravated - a phase IV clinical study of FDA data

Summary:

Hypertension aggravated is reported as a side effect among people who take Remodulin (treprostinil sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Opsumit, and have Pulmonary hypertension.

The phase IV clinical study analyzes which people have Hypertension aggravated when taking Remodulin. It is created by eHealthMe based on reports of 55,815 people who have side effects when taking Remodulin from the FDA, and is updated regularly.

What is Remodulin?

Remodulin has active ingredients of treprostinil sodium. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,843 Remodulin users. Check the latest studies of Remodulin.

What is Hypertension aggravated?

Hypertension aggravated (high blood pressure) is found to be associated with 2,749 drugs and 845 conditions by eHealthMe. Check the latest studies of Hypertension aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

55,815 people reported to have side effects when taking Remodulin.
Among them, 393 people (0.7%) have Hypertension aggravated.

Could Remodulin cause Hypertension aggravated?

Among these 393 people:

How long have people been on Remodulin when they have Hypertension aggravated? *

Click here to view more results

What is the gender of people who have Hypertension aggravated when taking Remodulin? *

Click here to view

What is the age of people who have Hypertension aggravated when taking Remodulin? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Remodulin and have Hypertension aggravated?

- Check whether Hypertension aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remodulin:

Remodulin (55,843 reports)

Hypertension aggravated treatments and more:

Hypertension aggravated (4,131 reports)

How severe was Hypertension aggravated and when was it recovered:

Hypertension aggravated in Remodulin

Expand to all the drugs that have ingredients of treprostinil sodium:

Hypertension aggravated and drugs with ingredients of treprostinil sodium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remodulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertension aggravated:

Hypertension aggravated (2,749 drugs)

Browse all the conditions that are associated with Hypertension aggravated:

Hypertension aggravated (845 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil sodium (the active ingredients of Remodulin) and Remodulin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.